Clinical analysis of patients with hepatitis B virus-related liver failure complicated with invasive pulmonary aspergillosis
10.3760/cma.j.issn.1000-6680.2011.01.008
- VernacularTitle:乙型肝炎病毒相关肝功能衰竭合并侵袭性肺曲霉菌病的临床特点与转归
- Author:
Wei WANG
;
Caiyan ZHAO
;
Yadong WANG
;
Hongzhu YIN
;
Yinghui LIU
;
Junying ZHOU
- Publication Type:Journal Article
- Keywords:
Hepatitis B virus;
Liver failure;
Lung diseases,fungal;
Aspergillosis;
Antifungal agents
- From:
Chinese Journal of Infectious Diseases
2011;29(1):34-40
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical features, risk factors, diagnose, treatments and prognosis of patients with hepatitis B virus (HBV)-related liver failure complicated with invasive pulmonary aspergillosis (IPA). Methods A case-control study was performed to retrospectively analyze the clinical data of 43 patients with HBV-related liver failure complicated with IPA. A cohort of 43 patients with HBV-related liver failure complicated with bacterial infection only was analyzed at the same time and another cohort of 43 patients with HBV-related liver failure without any infections served as the control group. Results Compared with the control group, patients with infection had lower platelet counts and prothrombin activity, higher scores of model for end-stage liver disease (MELD), especially the patients with IPA (F=42.43,13.69,14, 22, all P＜0.01). And the similar results were observed in patients with IPA group before and after Aspergillus infection (F= 12.09,14.52,-16.74, all P＜0.01). Furthermore, the annual mortality was 100. 0% in patients with IPA,which was higher than that of patients complicated with bacterial infection only; and both groups were higher than control group of patients without infection. The statistic results showed that patients with longer length of stay, more antibiotics usage, and more invasive procedures were all risk factors of HBV-related liver failure complicated with IPA. Conclusions Conditions of patients with HBV-related liver failure deteriorate rapidly after complicated with IPA and patients have higher mortality and poorer prognosis.Therefore, it will be effective to enhance the recognition of the early clinical manifestations, and make diagnosis timely and treat with potent anti-fungal therapy to improve their survival.
